AANA Journal Course: Perioperative Management of the Direct Acting Oral Anticoagulants (DOAC)

Availability: In stock


Quick Overview

General Price: $50.00

Associate Member (Student) Price: $21.00

Members Price: $35.00

1.0 Class A Credit

Course Expiration Date: 8/26/2022

Increase knowledge regarding DOAC's and newly approved reversal agents.



Overview of Course

The purpose of this activity is to increase knowledge regarding DOAC's and newly approved reversal agents.

Learner Outcomes

Upon completion of this course, the learner will be able to: 

  1. Describe the history of warfarin as an anticoagulant.
  2. Compare and contrast warfarin with the modern oral anticoagulants.
  3. Describe the sequencing of the coagulation cascade.
  4. List effective monitoring strategies for dabigatran, rivaroxaban, apixaban, and edoxaban.
  5. Discuss nonurgent and urgent reversal techniques for the most commonly prescribed oral anticoagulants.

Verification of Participation

The participant will have only 2 opportunities to successfully complete the course post-test, which is comprised of 5 random questions pulled from the test pool of questions. The passing score of at least 80% is required for the exam in this course. If the participant fails the post test, he or she will not receive CE credits for this course.

Accreditation Statement

This course has been prior approved by the AANA for 1.0 Class A CE credit; AANA Code Number: 1038109.

Course Expiration Date: 8/26/2022

The American Association of Nurse Anesthetists is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.